Skip to Content

TPV 250 (Aptivus 250 mg)

Generic Name: tipranavir

Pill with imprint TPV 250 is Pink, Capsule-shape and has been identified as Aptivus 250 mg. It is supplied by Boehringer Ingelheim Pharmaceuticals, Inc..

Aptivus is used in the treatment of hiv infection and belongs to the drug class protease inhibitors. Risk cannot be ruled out during pregnancy. Aptivus 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TPV 250

Aptivus

Generic Name
tipranavir
Imprint
TPV 250
Strength
250 mg
Color
Pink
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Protease inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Boehringer Ingelheim Pharmaceuticals, Inc.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00597-0003 Boehringer Ingelheim Pharmaceuticals, Inc.
54569-5719 A-S Medication Solutions, LLC (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.